References
- Alagaratnam S, Mertens BJ, Dalebout JC, et al (2008). Serum protein profiling in mice: identification of Factor XIIIa as a potential biomarker for muscular dystrophy. Proteomics, 8, 1552-63. https://doi.org/10.1002/pmic.200700857
- Baumann S, Ceglarek U, Fiedler GM, et al (2005). Standardized approach to proteome profiling of human serum based on magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem, 51, 973-80. https://doi.org/10.1373/clinchem.2004.047308
- Boja ES, Rodriguez H (2012). Mass spectrometry-based targeted quantitative proteomics: achieving sensitive and reproducible detection of proteins. Proteomics, 12, 1093-110. https://doi.org/10.1002/pmic.201100387
- Cadeco S, Williamson AJ, Whetton AD (2012). The use of proteomics for systematic analysis of normal and transformed hematopoietic stem cells. Curr Pharm Des, 18, 1730-50. https://doi.org/10.2174/138161212799859675
- Cheng AJ, Chen LC, Chien KY, et al (2005). Oral cancer plasma tumor marker identified with bead-based affinity-fractionated proteomic technology. Clin Chem, 51, 2236-44. https://doi.org/10.1373/clinchem.2005.052324
- Chinello C, Gianazza E, Zoppis I, et al (2010). Serum biomarkers of renal cell carcinoma assessed using a protein profiling approach based on ClinProt technique. Urology, 75, 842-47. https://doi.org/10.1016/j.urology.2009.09.050
- Cho WC (2007). Contribution of oncoproteomics to cancer biomarker discovery. Mol Cancer, 6, 25. https://doi.org/10.1186/1476-4598-6-25
- Cho WC (2007). Nasopharyngeal carcinoma: molecular biomarker discovery and progress. Mol Cancer, 6, 1.
- Ciccolallo L, Capocaccia R, Coleman MP, et al (2005). Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery. Gut, 54, 268-73. https://doi.org/10.1136/gut.2004.044214
- Compton CC, Greene FL (2004). The staging of colorectal cancer: 2004 and beyond. CA Cancer J Clin, 54, 295-308. https://doi.org/10.3322/canjclin.54.6.295
- Dai Y, Hu C, Wang L, et al (2010). Serum peptidome patterns of human systemic lupus erythematosus based on magnetic bead separation and MALDI-TOF mass spectrometry analysis. Scand J Rheumatol, 39, 240-6. https://doi.org/10.3109/03009740903456292
- Du J, Yang S, Lin X, et al (2010). Use of anchorchip-time-of-flight spectrometry technology to screen tumor biomarker proteins in serum for small cell lung cancer. Diagn Pathol, 5, 60. https://doi.org/10.1186/1746-1596-5-60
- Edwards BK, Ward E, Kohler BA, et al (2010). Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer, 116, 544-73. https://doi.org/10.1002/cncr.24760
- Engwegen JY, Depla AC, Smits ME, et al (2008). Detection of colorectal cancer by serum and tissue protein profiling: a prospective study in a population at risk. Biomark Insights, 3, 375-85.
- Fan NJ, Gao CF, Wang CS, et al (2012). Discovery and verification of gelsolin as a potential biomarker of colorectal adenocarcinoma in the Chinese population: Examining differential protein expression using an iTRAQ labelling-based proteomics approach. Can J Gastroentero, 26, 41-7.
- Fan NJ, Gao CF, Wang XL (2011). Identification of regional lymph node involvement of colorectal cancer by serum SELDI proteomic patterns. Gastroenterol Res Pract, 2011, 784967.
- Fan NJ, Gao CF, Wang CS, et al (2012).Identification of the up-regulation of TP-alpha, collagen alpha-1 (VI) chain, and S100A9 in esophageal squamous cell carcinoma by a proteomic method. J Proteomics, 75, 3977-86. https://doi.org/10.1016/j.jprot.2012.05.008
- Fan NJ, Gao CF, Zhao G, Wang XL, Qiao L (2012). Serum peptidome patterns for early screening of esophageal squamous cell carcinoma. Biotechnol Appl Biochem, 59, 276-82. https://doi.org/10.1002/bab.1024
- Fan NJ, Gao CF, Zhao G, Wang XL, Liu QY (2012).Serum peptidome patterns of breast cancer based on magnetic bead separation and mass spectrometry analysis. Diagn Pathol, 7, 45. https://doi.org/10.1186/1746-1596-7-45
- Garay JP, Gray JW (2012). Omics and therapy - a basis for precision medicine. Mol Oncol, 6, 128-39. https://doi.org/10.1016/j.molonc.2012.02.009
- Gemoll T, Roblick UJ, Auer G, Jornvall H, Habermann JK (2010).SELDI-TOF serum proteomics and colorectal cancer: a current overview. Arch Physiol Biochem, 116, 188-96. https://doi.org/10.3109/13813455.2010.495130
- Heckman-Stoddard BM (2012). Oncology biomarkers: discovery, validation, and clinical use. Semin Oncol Nurs, 28, 93-8. https://doi.org/10.1016/j.soncn.2012.03.003
- Huang YJ, Xuan C, Zhang BB, et al (2009). SELDI-TOF MS profiling of serum for detection of nasopharyngeal carcinoma. J Exp Clin Cancer Res, 28, 85. https://doi.org/10.1186/1756-9966-28-85
- Hudler P, Gorsic M, Komel R (2010). Proteomic strategies and challenges in tumor metastasis research. Clin Exp Metastasis, 27, 441-51. https://doi.org/10.1007/s10585-010-9339-7
- Issaq HJ, Xiao Z, Veenstra TD (2007): Serum and plasma proteomics. Chem Rev, 107, 3601-20. https://doi.org/10.1021/cr068287r
- Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Jemal A, Siegel R, Xu J, Ward E (2010).Cancer statistics2010. CA Cancer J Clin, 60, 277-300. https://doi.org/10.3322/caac.20073
- Ketterlinus R, Hsieh SY, Teng SH, Lee H, Pusch W (2005). Fishing for biomarkers: analyzing mass spectrometry data with the new ClinProTools software. Biotechniques, Suppl, 37-40.
- Liu LH, Shan BE, Tian ZQ, et al (2010). Potential biomarkers for esophageal carcinoma detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem Lab Med, 48, 855-61.
- Pang J, Liu WP, Liu XP, et al (2010).Profiling protein markers associated with lymph node metastasis in prostate cancer by DIGE-based proteomics analysis. J Proteome Res, 9, 216-26. https://doi.org/10.1021/pr900953s
- Pan C, He N, Zhao M, et al (2011). Subdividing the M1 stage of liver metastasis for nasopharyngeal carcinoma to better predict metastatic survival. Med Oncol, 28, 1349-55. https://doi.org/10.1007/s12032-010-9643-8
- Shin S, Cazares L, Schneider H, et al (2007). Serum biomarkers to differentiate benign and malignant mammographic lesions. J Am Coll Surg, 204, 1065-71; discussion 1071-3. https://doi.org/10.1016/j.jamcollsurg.2007.01.036
- Smith RA, Cokkinides V, Brooks D, et al (2011). Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin , 61, 8-30. https://doi.org/10.3322/caac.20096
- Tolson JP, Flad T, Gnau V, et al (2006). Differential detection of S100A8 in transitional cell carcinoma of the bladder by pair wise tissue proteomic and immunohistochemical analysis. Proteomics, 6, 697-708. https://doi.org/10.1002/pmic.200500033
- Wang Q, Shen J, Li ZF, et al (2009).Limitations in SELDI-TOF MS whole serum proteomic profiling with IMAC surface to specifically detect colorectal cancer. BMC Cancer, 9, 287. https://doi.org/10.1186/1471-2407-9-287
- West-Norager M, Kelstrup CD, Schou C, et al (2007). Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics. J Chromatogr B Analyt Technol Biomed Life Sci, 847, 30-7. https://doi.org/10.1016/j.jchromb.2006.09.048
- Whiteaker JR, Zhao L, Zhang HY, et al (2007). Antibody-based enrichment of peptides on magnetic beads for massspectrometry-based quantification of serum biomarkers. Anal Biochem, 362, 44-54. https://doi.org/10.1016/j.ab.2006.12.023
- Yao N, Chen H, Lin H, Deng C, Zhang X (2008). Enrichment of peptides in serum by C (8)-functionalized magnetic nanoparticles for direct matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analysis. J Chromatogr A, 1185, 93-101. https://doi.org/10.1016/j.chroma.2008.01.047
- Zethelius B, Berglund L, Sundstrom J, et al (2008).Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med, 358, 2107-16. https://doi.org/10.1056/NEJMoa0707064
Cited by
- Down-regulated MYH11 Expression Correlates with Poor Prognosis in Stage II and III Colorectal Cancer vol.15, pp.17, 2014, https://doi.org/10.7314/APJCP.2014.15.17.7223
- Plasma Phosphoproteome and Differential Plasma Phosphoproteins with Opisthorchis Viverrini-Related Cholangiocarcinoma vol.16, pp.3, 2015, https://doi.org/10.7314/APJCP.2015.16.3.1011
- Pemetrexed Induces G1 Phase Arrest and Apoptosis through Inhibiting Akt Activation in Human Non Small Lung Cancer Cell Line A549 vol.16, pp.4, 2015, https://doi.org/10.7314/APJCP.2015.16.4.1507
- Proteomic study of benign and malignant pleural effusion vol.142, pp.6, 2016, https://doi.org/10.1007/s00432-016-2130-7
- Selected reaction monitoring for colorectal cancer diagnosis using a set of five serum peptides identified by BLOTCHIP®-MS analysis vol.53, pp.11, 2018, https://doi.org/10.1007/s00535-018-1448-0